Onyx Pharmaceuticals to Present at UBS Global Life Sciences Conference
19 September 2008 - 6:00AM
PR Newswire (US)
EMERYVILLE, Calif., Sept. 18 /PRNewswire-FirstCall/ -- Onyx
Pharmaceuticals, Inc. (NASDAQ:ONXX) today announced that it will
present at the UBS Global Life Sciences Conference on Wednesday,
September 24, at 4:30 p.m. Eastern Time. Interested parties may
access a live webcast of the presentation on our website at:
http://www.onyx-pharm.com/wt/page/event_calendar It is recommended
that listeners log on 15 minutes early in order to register and
download any necessary software. For those unable to participate
during the live webcast, a recorded replay of the presentation will
be available within 24 hours of the completion of the presentation
through October 24, 2008. Onyx Pharmaceuticals, Inc. is a
biopharmaceutical company committed to improving the lives of
people with cancer by changing the way cancer is treated(TM). The
company, in collaboration with Bayer HealthCare Pharmaceuticals,
Inc., is developing and marketing Nexavar(R), a small molecule
drug. Nexavar is currently approved for the treatment of liver
cancer and advanced kidney cancer. Additionally, Nexavar is being
investigated in several ongoing trials in non-small cell lung
cancer, melanoma, breast cancer, and other cancers. For more
information about Onyx, visit the company's website at
http://www.onyx-pharm.com/. Nexavar(R) (sorafenib) tablets is a
registered trademark of Bayer Pharmaceuticals Corporation.
DATASOURCE: Onyx Pharmaceuticals, Inc. CONTACT: Alex Santos of Onyx
Pharmaceuticals, Inc., +1-510-597-6504 Web site:
http://www.onyx-pharm.com/
Copyright
Onyx Pharmaceuticals, Inc. (MM) (NASDAQ:ONXX)
Historical Stock Chart
From Jun 2024 to Jul 2024
Onyx Pharmaceuticals, Inc. (MM) (NASDAQ:ONXX)
Historical Stock Chart
From Jul 2023 to Jul 2024
Real-Time news about Onyx Pharmaceuticals, Inc. (MM) (NASDAQ): 0 recent articles
More Onyx Pharmaceuticals (MM) News Articles